Tiverton Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.28M Buy
11,474
+1,988
+21% +$221K 0.04% 264
2019
Q2
$1.05M Hold
9,486
0.04% 263
2019
Q1
$1.23M Hold
9,486
0.05% 218
2018
Q4
$1.1M Sell
9,486
-4,104
-30% -$458K 0.07% 166
2018
Q3
$1.46M Hold
13,590
0.07% 165
2018
Q2
$1.16M Buy
13,590
+2,304
+20% +$189K 0.06% 169
2018
Q1
$873K Sell
11,286
-1,412
-11% -$114K 0.06% 160
2017
Q4
$1.07M Buy
+12,698
New +$1.08M 0.07% 180

Other funds holding LLY

Tiverton Asset Management's LLY Position: Q3 2019 in Review

Tiverton Asset Management increased its Eli Lilly (LLY) stake by 21% in Q3 2019, buying an estimated $221K and bringing the position to 11,474 shares worth $1.28M. The position accounts for 0.04% of the portfolio, ranked #264.

Tiverton Asset Management first reported a position in LLY in Q4 2017 and has held it in 8 quarters since. The position peaked at $1.46M in Q3 2018. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Tiverton Asset Management held 11,474 shares of Eli Lilly worth $1.28M as of Q3 2019.
  • Tiverton Asset Management bought 1,988 Eli Lilly shares in Q3 2019, an estimated $221K.
  • Eli Lilly made up 0.04% of Tiverton Asset Management's portfolio in Q3 2019, its #264 holding.
  • Tiverton Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 8 quarters since.
  • Tiverton Asset Management's Eli Lilly position peaked at $1.46M in Q3 2018.
  • 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.